First Manhattan CO Nevro Corp Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 15, 2018	SELL	$44.22 - $75.47 $14.4 Million - $24.5 Million	-325,000 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$72.38 - $92.5 $369,138 - $471,750	5,100 Added 1.59%	325,000 $26 Million
Q1 2018 Apr 20, 2018	BUY	$69.46 - $88.57 $6.49 Million - $8.28 Million	93,500 Added 41.3%	319,900 $27.7 Million
Q4 2017 Jan 22, 2018	BUY	$65.94 - $93.31 $14.9 Million - $21.1 Million	226,400	226,400 $15.6 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.